Hematology-Oncology
Transforming Care in Follicular Lymphoma: Outcomes and Prognostic Insights in the Rituximab Era
This study analyzes treatment patterns, outcomes, and prognostic factors in 344 patients with transformed follicular lymphoma in the rituximab era, revealing poor event-free survival but moderate overall survival and high relapse rates, gui
